Long intergenic non-protein coding RNA 1826 (LINC01826)

Long intergenic non-protein coding RNA 1826 (LINC01826) is a human long non-coding RNA (lncRNA) gene located on chromosome 2q14.3, identified as ENSG00000232740 in Ensembl and 107985818 in NCBI Gene[1][3][5][7]. It is also known by the alias lnc-MKI67IP-3. LINC01826 does not encode a protein product and currently lacks any well-established molecular or disease functions in public genomic databases. There is no evidence that it acts as a therapeutic target, nor are there any known drug interactions or roles as a biomarker. Supporting Details & Sources: - LINC01826 is specifically annotated as a long non-coding RNA and not as a receptor, enzyme, transporter, or other canonical molecular drug target[1][3][5][7]. - GeneCards, Ensembl, BioGPS, and EMBL-EBI all consistently list it as a lncRNA with no protein product and do not assign any known biological or pathological role[1][3][5][7]. - No results provide evidence for its involvement in cellular signaling, disease mechanisms, or any known roles in drug response or disease pathology. - No drugs or mechanisms of action are listed for this gene, and it is not described as a biomarker or subject to specific therapeutic safety concerns. If more detailed biological function or disease association information emerges in future research or specialized datasets, this may need updating, but as of the current search, LINC01826 remains an uncharacterized lncRNA with no recognized role as a classical therapeutic target[1][3][5][7].

Other names

lnc-MKI67IP-3LNC-MKI67IP-3